Progyny Quarterly Balance Sheet
NASDAQ: PGNYHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Progyny financial position
As of Jun 30, 2026, Progyny reported total assets of $715.8 million, down 5.9% from a year earlier against total liabilities of $262.6 million. Shareholders' equity stood at $453.3 million, or 63.3% of assets. The company held $152.6 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.14, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Progyny balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 152.63M | 131.61M | 112.24M | 133.98M | 132.51M | 109.24M | 162.31M | 91.48M | 94.96M | 114.96M | 97.30M | 158.07M |
| Short-Term Investments | 84.29M | 93.50M | 197.86M | 211.22M | 172.59M | 146.88M | 65.64M | 144.24M | 167.23M | 256.87M | 273.79M | 177.48M |
| Receivables | 257.48M | 263.61M | 220.29M | 252.50M | 271.85M | 299.74M | 235.32M | 280.72M | 293.80M | 297.21M | 241.87M | 268.77M |
| Total Current Assets | 513.02M | 501.55M | 551.77M | 622.01M | 594.40M | 567.69M | 472.72M | 546.30M | 582.24M | 681.51M | 640.41M | 611.27M |
| Property, Plant & Equipment | 41.99M | 35.71M | 29.93M | 24.74M | 19.94M | 15.74M | 12.38M | 11.93M | 10.64M | 10.23M | 10.21M | 9.72M |
| Goodwill | 19.85M | 19.88M | 19.98M | 19.96M | 19.96M | 19.65M | 15.53M | 15.80M | 15.61M | 11.88M | 11.88M | 11.88M |
| Intangible Assets | 5.75M | 5.97M | 6.22M | 6.43M | 6.64M | 6.75M | 1.30M | 1.45M | 1.48M | — | 0 | 0 |
| Total Assets | 715.84M | 698.34M | 742.43M | 795.23M | 760.95M | 730.28M | 607.10M | 659.97M | 698.63M | 794.30M | 756.62M | 726.51M |
| Accounts Payable | 152.05M | 157.83M | 124.07M | 123.09M | 140.52M | 145.71M | 95.10M | 130.46M | 151.75M | 130.17M | 125.43M | 132.04M |
| Total Current Liabilities | 240.08M | 235.74M | 202.39M | 210.49M | 220.42M | 237.13M | 168.63M | 208.47M | 225.38M | 205.92M | 185.95M | 193.42M |
| Total Liabilities | 262.58M | 258.99M | 226.39M | 235.22M | 245.93M | 263.13M | 185.04M | 225.10M | 242.44M | 222.70M | 203.19M | 211.12M |
| Shareholders' Equity | 453.26M | 439.34M | 516.04M | 560.00M | 515.02M | 467.16M | 422.06M | 434.88M | 456.19M | 571.60M | 553.43M | 515.39M |
| Retained Earnings | 255.11M | 227.06M | 202.83M | 190.34M | 176.48M | 159.37M | 144.31M | 133.78M | 123.35M | 106.87M | 89.97M | 76.50M |
| Net Cash (Debt) | 236.93M | 225.11M | 310.10M | 345.21M | 305.09M | 256.12M | 227.95M | 235.72M | 262.19M | 371.83M | 371.09M | 335.55M |
| Shares Outstanding | 77.39M | 78.27M | 83.37M | 86.15M | 85.93M | 85.67M | 85.31M | 88.34M | 90.71M | 96.12M | 96.35M | 95.76M |
This table shows 12 quarterly periods of Progyny's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PGNY's reporting calendar. What is a balance sheet?